Condensed Statements of Cash Flows - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (5,000)	$ 3,740,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Payment by Founders of formation costs	5,000	0
Income from cash and investments held in Trust Account	0	(20,000)
Change in fair value of warrant liability	0	(3,895,000)
Changes in operating assets and liabilities:
Decrease in prepaid expenses		18,000
Increase in accounts payable		(24,000)
Increase in accrued liabilities	0	(50,000)
Net cash used in operating activities	0	(231,000)
Cash from financing activities
Proceeds from Sponsor Note	60,000	0
Proceeds from advances from Investors	0	0
Payment of deferred offering costs	(25,000)	0
Net cash provided from financing activities	35,000	0
Net change in cash	35,000	(231,000)
Cash at beginning of period	0	1,326,000
Cash at end of period	35,000	1,095,000
Supplemental disclosure of non-cash financing activities:
Sale of 6,468,750 of Class B ordinary shares to Founders and deposited with counsel for formation and deferred offering costs	25,000	0
Payment by Founders of deferred offering costs	20,000	0
Deferred offering costs included in accounts payable and accrued liabilities	$ 275,000	$ 0